A recent study has found that women with hypertension who take beta-blockers may face a higher risk of heart failure than men when they experience acute coronary syndrome.
The research, published in Hypertension and led by Dr. Raffaele Bugiardini from the University of Bologna, sheds light on the differing effects of beta-blockers based on biological differences between men and women.
Beta-blockers are widely prescribed medications used to lower blood pressure and prevent complications associated with hypertension, a leading cause of cardiovascular disease (CVD).
While effective in managing hypertension, this study suggests that the drugs may carry additional risks for women without prior CVD history.
The researchers analyzed data from 13,764 adults across 12 European countries. All participants had hypertension but no history of CVD. They were divided into two groups: those taking beta-blockers and those not taking them. Their outcomes were further categorized by sex.
Key findings from the study include:
- Women taking beta-blockers had a 4.6% higher rate of heart failure than men when presenting to the hospital with acute coronary syndrome.
- Heart failure significantly increased the risk of death for both men and women. Patients with heart failure were about seven times more likely to die compared to those who had a heart attack without complications.
- Women experiencing a serious type of heart attack known as ST-segment elevation myocardial infarction (STEMI) were 6.1% more likely to develop heart failure than men with the same condition. STEMI occurs when a coronary artery is completely blocked, cutting off blood flow to a large part of the heart muscle.
- Among participants not taking beta-blockers, men and women had similar rates of heart failure, suggesting the drug might contribute to the increased risk observed in women.
The findings highlight the need for personalized approaches to managing hypertension, particularly for women. Lifestyle changes, such as maintaining a healthy diet and engaging in regular exercise, may play a critical role in lowering blood pressure without relying solely on medication.
The study also raises questions about potential factors contributing to the increased risk in women. For example, interactions between hormone replacement therapy and beta-blockers may play a role, though the researchers did not investigate this in their study.
Other biological or hormonal differences could also influence how beta-blockers affect women compared to men.
Further research is needed to understand why women experience this elevated risk and to explore alternative treatment options that better address their unique health needs.
This study underscores the importance of considering sex-based differences in medical treatments to ensure better outcomes for all patients.
If you care about high blood pressure, please read studies about potatoes and high blood pressure, and top 10 choices for a blood pressure-friendly diet
For more information about high blood pressure, please see recent studies about impact of vitamins on high blood pressure you need to know, and the powerful link between high blood pressure and a potassium-rich diet.
Copyright © 2024 Knowridge Science Report. All rights reserved.
